The Rotronic Monitoring system (RMS) stores all recorded measurements securely in a system that the user can access at any time.
The Rotronic Monitoring system (RMS) stores all recorded measurements securely in a system that the user can access at any time. Data can be retrieved in any form and integrated into third-party systems. The server software, with a secure database, records all data and events, generating a range of alerts or warnings when customer-defined criteriaâ¨are breached. The RMS data loggers transmit theâ¨measured values to the software via wireless or local area network communication. The system sends error messages and alerts by voice call, e-mail, or text messages as well as smartphone apps.
The modular system is suitable for use in laboratories, cleanrooms, production and manufacturing processes, stability cabinets, and storage facilities. It is suitable for monitoring data reliably for building management systems and during the transportation of valuable products that are sensitive to variations in humidity and temperature levels.
Source: Rotronic
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.